Evolving Story of Clinical Trials in Hypertrophic Cardiomyopathy.

Perry M Elliott

Journal: Circulation. Heart failure 2019;11(1):e004572

PMID: 29321133

Abstract

Address: From the St Bartholomew's Hospital and the Institute of Cardiovascular Science, University College London, United Kingdom. [email protected].

DOI: 10.1161/CIRCHEARTFAILURE.117.004572

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/29321133

Subscription / membership required

Full Text Sources:

https://www.ahajournals.org/doi/10.1161/CIRCHEARTF...
https://www.ingentaconnect.com/openurl?genre=artic...
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Cardiomyopathy, Hypertrophic, Double-Blind Method, Humans, Ranolazine, Sodium Channel Blockers

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.